BioSpace News Archive

Press Releases

AlzeCure Publishes its Interim Report for January - March 2025

May 5, 2025
·
3 min read
Press Releases

Mammoth Biosciences Announces Nomination of MB-111 as First Development Candidate and Appoints Genetic Medicines Veteran Bob D. Brown to Board of Directors

May 5, 2025
·
4 min read
Press Releases

Aurinia Pharmaceuticals to Release First Quarter 2025 Financial and Operational Results on May 12, 2025

May 5, 2025
·
1 min read
Press Releases

Henry Schein Reports First Quarter 2025 Financial Results

May 5, 2025
·
20 min read
Press Releases

Regeneration Biomedical to Present Updated Phase 1 Trial Data on Autologous Stem Cell Therapy Injected Directly into the Brain for Alzheimer’s Disease in Podium Presentation at the ISCT 2025 Scientific Annual Meeting

May 5, 2025
·
6 min read
Press Releases

Axsome Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

May 5, 2025
·
18 min read
Press Releases

Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in Average Selling Price and Testing Volume

May 5, 2025
·
10 min read
Press Releases

Can-Fite Has Raised $175 Million in Total to Date for the Development of Namodenoson and Piclidenoson, Advancing into Pivotal Phase 3 Trials in Liver Cancer and Psoriasis

May 5, 2025
·
6 min read
Press Releases

International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers

May 5, 2025
·
6 min read
Press Releases

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - May 2, 2025

May 5, 2025
·
1 min read